MedTech Dive October 18, 2024
Nick Paul Taylor

The Center for Devices and Radiological Health intends to develop final guidance on its enforcement discretion policy regarding special controls for LDTs, among other topics.

Dive Brief:

  • The Food and Drug Administration released a list of the medical device guidance documents it plans to work on in its 2025 financial year, with topics like laboratory developed tests, artificial intelligence and cybersecurity filling out the agenda.
  • The list, which the FDA published last week, shows that the Center for Devices and Radiological Health intends to develop final guidance on its enforcement discretion policy regarding special controls for LDTs.
  • Other priorities include the finalization of documents on cybersecurity in premarket submissions and predetermined change control plans (PCCPs) for AI, plus the...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

Continue Reading

 
Topics: FDA, Govt Agencies, Provider
Related Articles:
Google’s Pixel Watch 3 Loss of Pulse Detection Feature Receives FDA Clearance
FDA Annual Flu Vaccine Meeting and CDC’s ‘Wild to Mild’ Campaign Canceled
Supporting the Development of Drugs for Rare Diseases — The Importance of Regulatory Transparency
Opinion: To fight for those with rare diseases, Trump must reform and modernize the FDA thoughtfully
5 Rare Diseases That Now Have Their First FDA-Approved Treatments

Share This Article